Contact this trialFirst, we need to learn more about you.
ESK-001 for Psoriasis
Recruiting1 awardPhase 3
Walnut Creek, California
This trial aims to see if ESK-001 is effective in treating moderate to severe plaque psoriasis and how safe it is for patients. Participants will take ESK-001 daily for 24 weeks
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.